Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations
Diabetes, Metabolic Syndrome and Obesity · 2026-01 · Volume 19 · 1-13
DOI: 10.2147/dmso.s584175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-01. Verfasst von Nimet Yılmaz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey.
- Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey.
ORCID-Profile: Nimet Yılmaz, Mehmet Bastemir
Zitieren
APA
Yılmaz, N., & Bastemir, M. (2026). Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-13. https://doi.org/10.2147/dmso.s584175
Vancouver
Yılmaz N, Bastemir M. Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-13. doi:10.2147/dmso.s584175
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, Nimet and Bastemir, Mehmet},
title = {Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/dmso.s584175}
}
EUVIMED